Markets
Delta jets
(Andrew Harnik/Getty Images)

Delta, American, and rival airlines boost Q1 sales outlooks, citing strong demand; costs rise, too

Airlines are soaring as they say revenue is coming in higher than expected in the first quarter. That’s likely in part because they’re raising ticket prices to account for higher fuel costs.

Delta Air Lines shares are up 5% in premarket trading on Tuesday, following a boost to the company’s first-quarter sales guidance.

Speaking at a JPMorgan conference on Tuesday, Delta said it now expects Q1 revenue growth in the high single digits, up from its previous forecast of 5% to 7% growth. The company now expects Q1 revenue of up to $15.3 billion.

Rival carriers, also presenting at the conference, similarly boosted their revenue forecasts on stronger-than-expected travel demand in the quarter.

It’s worth noting that these are revisions to forecasts for the first quarter — of which roughly one-third is occurring during the war in the Middle East, which has driven oil costs sky-high and boosted ticket prices. According to a Deutsche Bank note from Monday, last week’s walk-up fares for Delta were up 20% year over year, while United’s were up 53.2%.

The airlines’ numbers likely also include a wave of people panic-buying tickets as they worry about prices rising in the future.

“Jet fuel, for those unaware, has almost doubled since the start of the year. So it’s not just the crude prices, but the cracks are also significantly higher than they were,” said Delta CEO Ed Bastian, who added that there’s been a “$400 million fuel spike just in the month of March.”

American Airlines said it now expects Q1 year-over-year sales growth of more than 10%, up from its prior guidance of 7% to 10%. The carrier also said its adjusted earnings per share will come in at the lower end of guidance, citing rapidly rising jet fuel costs.

JetBlue upped its operating revenue per seat mile outlook to between 5% and 7% for the first quarter, up from its prior range of 0% to 4%. According to JetBlue, demand helped to “partially offset additional expenses realized from operational disruptions and rising fuel costs.”

Budget carrier Frontier said revenue per seat mile is now expected to increase by the mid-teens, compared to its earlier guidance of more than 10%. The carrier said higher jet fuel prices will drive an additional $45 million to $50 million incremental fuel expense in the quarter.

Southwest Airlines and United Airlines, which are also set to present at the conference on Tuesday, were similarly up in premarket trading. This story will be updated as additional carriers present.

More Markets

See all Markets
markets

Oklo surges after receiving approval for next phase in the construction of its first reactor

Revenue-free retail favorite Oklo is up in early trading after announcing regulatory updates on its first product, a reactor it calls Aurora, which it has started building at the US Energy Department’s primary nuclear energy research and development center, the Idaho National Laboratory.

Oklo announced that it signed an “other transaction agreement” (OTA) with the Department of Energy early Tuesday. (OTAs are typically used by the federal government to enter into research, prototyping, and production deals with private entities outside of the typical procurement processes.)

Oklo also announced that the DOE’s Idaho Operations Office also signed off on a preliminary safety design review for the reactor, which is expected to be completed sometime in late 2027 or 2028. The company broke ground on the project in September.

Separately, Oklo also announced that the Nuclear Regulatory Commission issued a materials license enabling an Oklo subsidiary to handle, process, and distribute isotopes.

“This is Oklo’s first NRC-issued license and supports the transition from design and planning to real-world execution and progress,” the company said.

Given the close involvement of the federal government in the development of nuclear power plants, Oklo’s close ties to the Trump administration have been seen as an important advantage for the company — but have also drawn scrutiny and criticism.

Energy Secretary Chris Wright was formerly a board member at Oklo, before he was tapped to lead the Trump administration’s Department of Energy.

The department is playing a more prominent role in the nuclear regulatory process under an executive order designed to speed up approval of new nuclear energy technologies.

Separately, Oklo is due to report earnings after the close of trading on Tuesday.

Oklo announced that it signed an “other transaction agreement” (OTA) with the Department of Energy early Tuesday. (OTAs are typically used by the federal government to enter into research, prototyping, and production deals with private entities outside of the typical procurement processes.)

Oklo also announced that the DOE’s Idaho Operations Office also signed off on a preliminary safety design review for the reactor, which is expected to be completed sometime in late 2027 or 2028. The company broke ground on the project in September.

Separately, Oklo also announced that the Nuclear Regulatory Commission issued a materials license enabling an Oklo subsidiary to handle, process, and distribute isotopes.

“This is Oklo’s first NRC-issued license and supports the transition from design and planning to real-world execution and progress,” the company said.

Given the close involvement of the federal government in the development of nuclear power plants, Oklo’s close ties to the Trump administration have been seen as an important advantage for the company — but have also drawn scrutiny and criticism.

Energy Secretary Chris Wright was formerly a board member at Oklo, before he was tapped to lead the Trump administration’s Department of Energy.

The department is playing a more prominent role in the nuclear regulatory process under an executive order designed to speed up approval of new nuclear energy technologies.

Separately, Oklo is due to report earnings after the close of trading on Tuesday.

markets

Eli Lilly receives its only sell rating from HSBC, which cites smaller market for weight-loss drugs

Eli Lilly slipped in early trading after analysts at HSBC gave the pharmaceutical darling at the center of the obesity drug boom a rare downgrade.

Analysts at the bank cut their rating to “reduce” from “hold.” They cut their price target to $850 from $1,070. The stock closed at $989 on Monday.

According to Bloomberg, this is the only sell rating on Lilly among the 38 analysts who cover the stock.

The company has rallied more than 20% in the past year as its obesity drug sales continue to rise, far outpacing its top rival, Novo Nordisk. But the space is getting increasingly crowded with new entrants as well as new products from Lilly and Novo, putting downward pricing pressure on their products.

HSBC: ".. We downgrade Lilly to Reduce (from Hold) as we cut our medium-term forecasts for the market .. We think Lilly shares are priced to perfection .. and think medium-term earnings trends are optimistic. .. the total addressablemarket (TAM) for obesity might be USD80-120bn (not >USD150bn)."

— Carl Quintanilla (@carlquintanilla.bsky.social) March 17, 2026 at 12:24 PM
markets

Nebius drops after announcing that it aims to raise $3.75 billion in a convertible loan offering

Nebius dropped as much as 7.5% in premarket trading on Tuesday, after the AI infrastructure company announced its intentions to sell $3.75 billion worth of convertible senior notes with maturities in 2031 and 2033.

The company will offer the debt in two tranches, the first batch worth $2 billion and due March 15, 2031, followed by $1.75 billion worth of notes due March 15, 2033. There’s also the potential for an additional $562.5 million of these notes to be issued via an over-allotment option.

The interest and initial conversion rate will be determined at the pricing of the offering, but regardless of the premium, a $3.75 billion offering would be pretty sizable for a company that closed yesterday’s trading session with a ~$33 billion market cap, and the market is quickly pricing in a decent chunk of equity dilution.

The offering is conspicuous in its timing, with Nebius soaring 15% yesterday on the back of a major infrastructure deal with Meta — worth up to $27 billion over five years.

The funds will likely be put to good use to deliver on some of these major projects. Per the company’s press release, the capital raised will be used to:

“...finance the continuing growth of its business, including expenditures related to the construction and build-out of its data centers, investments to develop its full-stack AI cloud, the expansion of its data center footprint and the procurement of key components (including GPUs), and for general corporate purposes.”

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.